Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tingyu Liang, Yixuan Song, Lingui Gu, Yu Wang & Wenbin Ma. (2023) Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma. International Journal of General Medicine 16, pages 4121-4141.
Read now
Read now
Fernanda Pohl-Guimarães, Lan B. Hoang-Minh & Duane A. Mitchell. (2020) RNA-electroporated T cells for cancer immunotherapy. OncoImmunology 9:1.
Read now
Read now
Xuequn Xu, Jin Qiu & Yi Sun. (2017) The basics of CAR T design and challenges in immunotherapy of solid tumors — Ovarian cancer as a model. Human Vaccines & Immunotherapeutics 13:7, pages 1548-1555.
Read now
Read now
Articles from other publishers (8)
Payal D. Shah, Alexander C. Huang, Xiaowei Xu, Robert Orlowski, Ravi K. Amaravadi, Lynn M. Schuchter, Paul Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E. John Wherry, Gerald P. Linette, Andrea Brennan, Vanessa Gonzalez, Irina Kulikovskaya, Simon F. Lacey, Gabriela Plesa, Carl H. June, Robert H. Vonderheide & Tara C. Mitchell. (2023) Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma. Cancer Research Communications 3:5, pages 821-829.
Crossref
Crossref
Jessica B Foster, Crystal Griffin, Jo Lynne Rokita, Allison Stern, Cameron Brimley, Komal Rathi, Maria V Lane, Samantha N Buongervino, Tiffany Smith, Peter J Madsen, Daniel Martinez, Alberto Delaidelli, Poul H Sorensen, Robert J Wechsler-Reya, Katalin Karikó, Phillip B Storm, David M Barrett, Adam C Resnick, John M Maris & Kristopher R Bosse. (2022) Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. Journal for ImmunoTherapy of Cancer 10:9, pages e004450.
Crossref
Crossref
Arthur J. Van De Vyver, Estelle Marrer-Berger, Ken Wang, Thorsten Lehr & Antje-Christine Walz. (2021) Cytokine Release Syndrome By T-cell–Redirecting Therapies: Can We Predict and Modulate Patient Risk?. Clinical Cancer Research 27:22, pages 6083-6094.
Crossref
Crossref
Jessica B. FosterNamrata ChoudhariJessica PerazzelliJulie StormTed J. HofmannPayal JainPhillip B. StormNorbert PardiDrew WeissmanAngela J. WaandersStephan A. GruppKatalin KarikóAdam C. ResnickDavid M. Barrett. (2019) Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response. Human Gene Therapy 30:2, pages 168-178.
Crossref
Crossref
Jian Li, Wenwen Li, Kejia Huang, Yang Zhang, Gary Kupfer & Qi Zhao. (2018) Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward. Journal of Hematology & Oncology 11:1.
Crossref
Crossref
Chien-Fu Hung, Xuequn Xu, Linhong Li, Ying Ma, Qiu Jin, Angelia Viley, Cornell Allen, Pachai Natarajan, Rama Shivakumar, Madhusudan V. Peshwa & Leisha A. Emens. (2018) Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy. Human Gene Therapy 29:5, pages 614-625.
Crossref
Crossref
Wei Xia Ang, Zhendong Li, Zhixia Chi, Shou-Hui Du, Can Chen, Johan C.K. Tay, Han Chong Toh, John E. Connolly, Xue Hu Xu & Shu Wang. (2017) Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis. Oncotarget 8:8, pages 13545-13559.
Crossref
Crossref
Bing-Lan Zhang, Di-Yuan Qin, Ze-Ming Mo, Yi Li, Wei Wei, Yong-Sheng Wang, Wei Wang & Yu-Quan Wei. (2016) Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors. Science China Life Sciences 59:4, pages 340-348.
Crossref
Crossref